Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:24 AM UTC
| NCT Number | NCT05281809 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | John Lister |
| Last Updated on CT.gov | January 13, 2025 (Jan 13, 2025) |
As of July 17, 2026: Clinical trial NCT05281809 is currently recruiting participants. This phase2 study for b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by John Lister. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05281809 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05281809 was last updated Jan 13, 2025 (January 13, 2025). HelloStudys verifies this status automatically.